Sorrento Therapeutics Inc (SRNE)

[dia76ca]

On Dec. 5 Sorrento announced that they were in the late stage of the pre-clinical phase of oral MP18 anti-viral against all Covid variants including OMICRON!
" “We are pleased to work with Prof. Liu’s group at Texas A&M University to develop a more effective oral MPro inhibitor to meet the urgent need for treatment of COVID-19 patients infected with existing and emerging variants. The oral MPro inhibitor together with Sorrento’s other ongoing therapeutic intervention approaches reflect our efforts to create a ‘mutation-agnostic’ global anti-COVID strategy to combat COVID-19 variants of concern, including the emerging Omicron variant,” stated Dr. Henry Ji, Chairman and CEO of Sorrento."

I expect a clinical trial in Q1 of 2022.